newsfilter
← Latest News
FDA Approved Drugs·

Approval of Wellbutrin Sr, Nda #020358 (Labeling)

Approval Date: 11/05/2025; Drug Name: Wellbutrin Sr, Nda #020358; Active Ingredients: BUPROPION HYDROCHLORIDE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020358

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE